SMAD3 and hepatocellular carcinoma: Nagata showed that the inhibition of JNK switches Smad3 signaling from oncogenic pSmad3L/c-Myc to tumor-suppressive pSmad3C/p21WAF1 in DEN-induced rat hepatocellular carcinoma [31].